Victory Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$818K Buy
25,386
+1,592
+7% +$58.9K ﹤0.01% 1909
2025
Q4
$1M Sell
23,794
-12,596
-35% -$508K ﹤0.01% 1835
2025
Q3
$1.25M Sell
36,390
-88,191
-71% -$2.53M ﹤0.01% 1739
2025
Q2
$3.37M Buy
124,581
+26,795
+27% +$776K ﹤0.01% 1440
2025
Q1
$2.9M Buy
97,786
+41,248
+73% +$1.57M ﹤0.01% 1441
2024
Q4
$2.24M Sell
56,538
-28,905
-34% -$1.09M ﹤0.01% 1469
2024
Q3
$2.91M Sell
85,443
-2,112
-2% -$59.4K ﹤0.01% 1389
2024
Q2
$1.9M Buy
87,555
+15,647
+22% +$329K ﹤0.01% 1452
2024
Q1
$1.59M Buy
71,908
+649
+0.9% +$15.8K ﹤0.01% 1527
2023
Q4
$1.96M Buy
71,259
+14,219
+25% +$343K ﹤0.01% 1431
2023
Q3
$1.27M Buy
57,040
+137
+0.2% +$3.52K ﹤0.01% 1539
2023
Q2
$1.45M Buy
56,903
+39,336
+224% +$954K ﹤0.01% 1508
2023
Q1
$392K Buy
+17,567
New +$425K ﹤0.01% 2066
2022
Q4
Sell
-43,929
Closed -$729K 2716
2022
Q3
$729K Sell
43,929
-49,247
-53% -$1.11M ﹤0.01% 1873
2022
Q2
$1.85M Buy
93,176
+38,329
+70% +$774K ﹤0.01% 1493
2022
Q1
$1.12M Buy
54,847
+86
+0.2% +$2.46K ﹤0.01% 1742
2021
Q4
$2.26M Sell
54,761
-8,732
-14% -$386K ﹤0.01% 1517
2021
Q3
$2.95M Sell
63,493
-3,508
-5% -$153K ﹤0.01% 1464
2021
Q2
$2.68M Sell
67,001
-1,076
-2% -$46K ﹤0.01% 1546
2021
Q1
$3.66M Sell
68,077
-4,793
-7% -$276K ﹤0.01% 1453
2020
Q4
$3.57M Sell
72,870
-6,774
-9% -$314K ﹤0.01% 1333
2020
Q3
$2.59M Sell
79,644
-25,545
-24% -$812K ﹤0.01% 1370
2020
Q2
$2.72M Sell
105,189
-105,319
-50% -$2.62M ﹤0.01% 1336
2020
Q1
$5.12M Buy
210,508
+106,540
+102% +$2.68M ﹤0.01% 1263
2019
Q4
$2.9M Buy
103,968
+8,415
+9% +$218K ﹤0.01% 1365
2019
Q3
$2.29M Buy
+95,553
New +$2.54M ﹤0.01% 1401
2019
Q1
Sell
-221,200
Closed -$2.78M 1877
2018
Q4
$2.78M Sell
221,200
-8,800
-4% -$104K 0.01% 958
2018
Q3
$2.2M Buy
+230,000
New +$2.54M ﹤0.01% 1085

Other funds holding VCYT

Victory Capital Management's VCYT Position: Q1 2026 in Review

Victory Capital Management increased its Veracyte (VCYT) stake by 6.7% in Q1 2026, buying an estimated $58.9K and bringing the position to 25,386 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Victory Capital Management first reported a position in VCYT in Q3 2018 and has held it in 28 quarters since. The position peaked at $5.12M in Q1 2020. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Victory Capital Management held 25,386 shares of Veracyte worth $818K as of Q1 2026.
  • Victory Capital Management bought 1,592 Veracyte shares in Q1 2026, an estimated $58.9K.
  • Veracyte made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1909 holding.
  • Victory Capital Management first reported a position in Veracyte in Q3 2018 and has held it in 28 quarters since.
  • Victory Capital Management's Veracyte position peaked at $5.12M in Q1 2020.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.